PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma

NCT05714306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Ovarian Carcinoma

Interventions

BIOLOGICAL: PEP-DC1
BIOLOGICAL: OC-DC
BIOLOGICAL: PEP-DC2
DRUG: Low dose cyclophosphamide

Sponsor

Centre Hospitalier Universitaire Vaudois